MPC1 and prostate carcinoma: In prostate cancer cells, chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) inhibits the promoter activity of mitochondrial pyruvate carrier 1 (MPC1) [12], leading to decreased mitochondrial pyruvate oxidation and a glycolytic metabolic phenotype.